Skip to content
Search

Latest Stories

India's Stelis Biopharma to produce 200 million doses of Russia's Sputnik V

India's Stelis Biopharma to produce 200 million doses of Russia's Sputnik V
Pramod Thomas
By Pramod ThomasMar 19, 2021
Pramod Thomas
See Full Bio

THE developer of Russia's Sputnik V coronavirus vaccine said Friday (19) it had signed a partnership with an India-based drugmaker for the production of 200 million doses of the two-dose jab.

The Russian Direct Investment Fund (RDIF), which backed the development of Sputnik V, said in a statement it had partnered with Stelis Biopharma 'to produce and supply a minimum of 200 million doses of the Russian Sputnik V vaccine'.

Stelis Biopharma is expected to be able to start supplying the vaccine from the second half of the year.

RDIF, added that Stelis -- the biopharma unit of global pharmaceutical company Strides -- will work with the Russian wealth fund to provide supplies 'beyond the initial agreement'.

RDIF head Kirill Dmitriev said that the "significant vaccine volumes" produced with Stelis "will help widen access to the vaccine on a global scale".

RDIF said Friday that 52 countries have approved the use of Russia's Sputnik V, named after the Soviet-era satellite.

Moscow registered the jab in August before large-scale clinical trials, but leading medical journal The Lancet has since said it is safe and over 90 per cent effective.

Some Western countries have been wary of Sputnik over concerns the Kremlin would use it as a soft power tool to advance its interests.

stelis biopharmasputnik v vaccine

Related News

pride queer films
Entertainment

Pride Month binge guide: 10 iconic queer films now streaming that’ll stay with you

Priyanka Chopra
Entertainment

Priyanka Chopra turns heads in white cut-out gown at ‘Heads of State’ New York screening

The Family Man season 3
TV

‘The Family Man’ season 3 confirmed as Manoj Bajpayee returns with Sundeep Kishan joining cast

More For You

Lidl Tower air fryer

All Tower 8Ltr Dual Basket Air Fryers sold at Lidl GB are affected

Lidl

Lidl Tower air fryer recall warns of overheating risk in popular model

Key points

  • Lidl GB recalls Tower 8Ltr Dual Basket Air Fryers (model T17129L)
  • Safety issue identified: risk of overheating and potential fire hazard
  • Customers urged to stop using the product immediately
  • Returns can be arranged viawww.tower-safety.co.uk

  • Lidl confirms no other Tower products affected

Fire hazard prompts urgent recall of air fryer model

Lidl GB has recalled a popular kitchen appliance due to serious safety concerns. The Lidl Tower air fryer recall affects all stock of the Tower 8Ltr Dual Basket Air Fryer, model number T17129L, after the discovery of a potential fire risk linked to overheating.

The retailer’s supplier identified that the affected units may overheat during use, posing a fire hazard. As a result, Lidl has urged customers to “stop using it immediately” and begin the return process.

Keep ReadingShow less
How to make the most of a physician assistant internship

How to make the most of a physician assistant internship

A physician assistant (PA) internship isn't just another step in your education; it's a pivotal moment that can define your future in medicine. This is where you can seamlessly connect classroom theory with real-world practice, sharpen your clinical expertise, and develop your professional identity.

But to truly make the most of this experience, simply showing up isn't enough. Here's how to approach your internship with purpose and intention.

Keep ReadingShow less
Weight Loss Drug

Health officials expect the rollout to benefit around 220,000 adults over the next 3 years

iStock

NHS GPs to prescribe Mounjaro in nationwide obesity treatment plan

Key points

  • NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
  • The programme aims to support 220,000 people over three years
  • Eligible patients must have a BMI over 40 and at least four obesity-related health issues
  • GP leaders raise concerns over increased workload
  • Pharmacists urge a broader weight management approach

NHS expands obesity treatment with Mounjaro

The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.

Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.

Keep ReadingShow less
UK heatwave deaths

Around 85% of the projected deaths are likely to involve people over the age of 65

iStock

Scientists warn current UK heatwave may cause nearly 600 early deaths

Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.

Climate change driving deadly temperatures

Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.

Keep ReadingShow less
From silence to spotlight: How Ella D’Verma turned her truth into power

In a world still catching up with the truths of trans identity

Instagram / elladverma

From silence to spotlight: How Ella D’Verma turned her truth into power

AS Pride Month sweeps across the world in a blaze of colour, protest and celebration, one Indian voice continues to rise with unwavering authenticity. Ella D’Verma is reshaping narratives as a transgender model, fearless LGBTQ+ advocate and digital content creator with a powerful global following.

In a world still catching up with the truths of trans identity, her visibility has become vital – the embodiment of pride in action. In this exclusive conversation with Eastern Eye, she speaks about her journey, the importance of visibility, self-expression, navigating the fashion industry as a trans model, representation, and her vision for the future.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Asian Media Group USA Inc